This inventor holds 1 USPTO granted patent. Top assignee: Frim International, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: John M Trenkle: Innovator in Mosaic Construction and Processing
Introduction
John M Trenkle is an accomplished inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of electronic imaging through his innovative patent. His work focuses on the acquisition and processing of large-scale transmission electron micrograph composite images.
Latest Patents
John M Trenkle holds a patent for a method titled "Mosaic construction, processing, and review of very large electronic." This patent describes a method for the acquisition, mosaicking, cueing, and interactive review of large-scale transmission electron micrograph composite images. The process involves automatically registering and mosaicing individual frames into a single virtual image composite. This composite is then utilized for automatic cueing of axons and axon clusters, as well as for review and marking by qualified neuroanatomists. The statistics derived from this review process are instrumental in evaluating the efficacy of drugs in promoting the regeneration of myelinated nerve fibers. He has 1 patent to his name.
Career Highlights
John M Trenkle is associated with Frim International, Inc., where he applies his expertise in electronic imaging. His innovative approach has paved the way for advancements in neuroanatomy and drug efficacy evaluation.
Collaborations
One of his notable collaborators is Robert C Vogt, III. Their partnership has contributed to the development and refinement of techniques in the field of electronic imaging.
Conclusion
John M Trenkle's contributions to the field of electronic imaging through his innovative patent demonstrate his commitment to advancing technology in neuroanatomy. His work continues to impact the evaluation of drug efficacy and the understanding of nerve fiber regeneration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile